{"ticker": {"uuid": "f8d31581-1c61-4903-9047-b5c7ad9fbc06", "symbol": "9995", "name": "RemeGen Co., Ltd.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Shareholder Meeting Live | RemeGen: Has Assembled a New Team to Expand Hospital Channels or May Seek Bundled BD Licensing Partnerships", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPVDZ0M3FESGVXbHh5OEtVVl9SVTJWNHRFeW5sa2lfLWU2NkZqNHUzQndGNjJlekRyUjRuMUZFaXlfLVZBV1JWRnlSZzJMT1JZN1lvVmNFaW1RYW5pbURTU04zQ3JET0JWZlBvQjVpUU12Q3M2UHlwV0pjWUZsejBPUnJxcnAxa2F2ZmR6OV9hVG8yV09JRm9kU1poX1dtRVM3ekhZ?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-22T02:30:48+00:00", "published_display": "22 Jun 2026 02:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen (SEHK:9995) Stock Could Be 39% Below Fair Value After Telitacicept Approvals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen scores out-licensing triple play with AbbVie deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPYzRSb1NuaXBnbTF2N0pENEVLSmFmWGZHY1NITW1KX0lyOUZob1JSV21XemZkUVNoOHdnaEsyaVNiWUxBMmdaRVVaRDlRaUdIeXFYUkd4bVY1OUJqRnN1MjBYZERzY183R1lDWnRHaC1ERUs3YUxWNGNQTUhrWHNobWpxTkZ3dmVQOTVBR0h3?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxNd1gxZ0tUU0dxMkN2bjRNQVptQXBJODBXTEpsRklRMFc5TkVCN0lOUGM3SUh3eEFTakUwZGRJbW1vM2V2aEFoMGFXZFc1b181MWJoY054ckx3WGR6RzhnakhPTkVxeUF1bkZfXzd3YW53NFI5T0xyS2xlcFBvT1FJNXN4UVY4NXVLU1dnRHdGVFNocnVYaW92RkQtVmZjZWxra20yLXl3MFFFZnpWbG5LeDI0TWxNSWQyUjZUTUxqN0FOSER2bF9tQl81b19McE5nSGQ4VzRvc0pNbmttekxGVThZVjhSaEEwMHkyeHliRVZhU19IYXF1clFRdFZja2VfS0FwbHNqUWoycUU4YXBsZjVONmxhRlhhVVE?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After axing 95% workforce, Vor bets $4B+ on Remegen\u2019s telitacicept", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOU19EdmNCLTBsZUI1bzZIZEhJdmlIQ0xNaGdTZnJtdS1CUHJFbm5rbVYyVy1ucjZiQi1EYXZjMHJJd3dGMTVSaFpJMzhMcXBHSXJoUmU0VDZmc0lpYzgwRFg1T3lKUTVva3QzejI0YmRQdTg0cUNkSm5HTlJweFlGcFFWXzBEbjJWVjlob0Q0Unh1NXhzNW5Id0k1Uk5SYURlQXJQag?oc=5", "source_name": "BioWorld News", "published_at": "2025-06-26T07:00:00+00:00", "published_display": "26 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Macnica, Inc. completed the acquisition of an 85.56% stake in GLOSEL Co., Ltd. from SAXA, Inc. and others for \u00a518.9 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwJBVV95cUxQOFJ4SXNsdFJub0hHQnVBNGNOWDAwVEppc0NPUElHME5Ic2J6dTR1VzlDdWJsOVdtcWdwdXo3TXYyOC1aNlM5ekJTUnlhS0NPNXlwa09CTzZoUnByRndFX1VhN2ZUMmJDYkNlRnVTcWpMQWJCTVkwaXNtXzRad094dWZrNG9QZG1ydVRGSmlJV2F3QnhoZm11a3FnSEM0aFhEWDVsU3YyVEFFZ2xjd183OVN1bGM5TEkzQXRnNUhIM2ZVYWxvY19KTzAzYUJIeUtvd29VVHQ0NGpQTXpGTzdzUEVab0JLR1JkUk5aVnZoaUdXazNmUXdKTHhWSXFFRmV0Xzgw?oc=5", "source_name": "marketscreener.com", "published_at": "2024-02-27T08:00:00+00:00", "published_display": "27 Feb 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REMEGEN CO., LTD. - H SHARES (9995) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQZEpmMGE3SFh3THpNS0p2ZGlUM0tQcjV5MTdwZW5Sc1VVMVEtVGFjbHROc0RTZmh6YWpFc2Q5VDVzWFJtZ2JSLTdYdzk5MFFOc0tKM2VlV25fR1lwaEhXNGhXb1RVTEJEdVFHWWNqNWgwS2hqR1BsVHJvTUxWVU5IclNsbGt6LTN6QWhQTEd0SQ?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-11-09T08:00:00+00:00", "published_display": "09 Nov 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Shareholder Meeting Live | RemeGen: Has Assembled a New Team to Expand Hospital Channels or May Seek Bundled BD Licensing Partnerships", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPVDZ0M3FESGVXbHh5OEtVVl9SVTJWNHRFeW5sa2lfLWU2NkZqNHUzQndGNjJlekRyUjRuMUZFaXlfLVZBV1JWRnlSZzJMT1JZN1lvVmNFaW1RYW5pbURTU04zQ3JET0JWZlBvQjVpUU12Q3M2UHlwV0pjWUZsejBPUnJxcnAxa2F2ZmR6OV9hVG8yV09JRm9kU1poX1dtRVM3ekhZ?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-22T02:30:48+00:00", "published_display": "22 Jun 2026 02:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen (SEHK:9995) Stock Could Be 39% Below Fair Value After Telitacicept Approvals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen scores out-licensing triple play with AbbVie deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPYzRSb1NuaXBnbTF2N0pENEVLSmFmWGZHY1NITW1KX0lyOUZob1JSV21XemZkUVNoOHdnaEsyaVNiWUxBMmdaRVVaRDlRaUdIeXFYUkd4bVY1OUJqRnN1MjBYZERzY183R1lDWnRHaC1ERUs3YUxWNGNQTUhrWHNobWpxTkZ3dmVQOTVBR0h3?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxNd1gxZ0tUU0dxMkN2bjRNQVptQXBJODBXTEpsRklRMFc5TkVCN0lOUGM3SUh3eEFTakUwZGRJbW1vM2V2aEFoMGFXZFc1b181MWJoY054ckx3WGR6RzhnakhPTkVxeUF1bkZfXzd3YW53NFI5T0xyS2xlcFBvT1FJNXN4UVY4NXVLU1dnRHdGVFNocnVYaW92RkQtVmZjZWxra20yLXl3MFFFZnpWbG5LeDI0TWxNSWQyUjZUTUxqN0FOSER2bF9tQl81b19McE5nSGQ4VzRvc0pNbmttekxGVThZVjhSaEEwMHkyeHliRVZhU19IYXF1clFRdFZja2VfS0FwbHNqUWoycUU4YXBsZjVONmxhRlhhVVE?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After axing 95% workforce, Vor bets $4B+ on Remegen\u2019s telitacicept", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOU19EdmNCLTBsZUI1bzZIZEhJdmlIQ0xNaGdTZnJtdS1CUHJFbm5rbVYyVy1ucjZiQi1EYXZjMHJJd3dGMTVSaFpJMzhMcXBHSXJoUmU0VDZmc0lpYzgwRFg1T3lKUTVva3QzejI0YmRQdTg0cUNkSm5HTlJweFlGcFFWXzBEbjJWVjlob0Q0Unh1NXhzNW5Id0k1Uk5SYURlQXJQag?oc=5", "source_name": "BioWorld News", "published_at": "2025-06-26T07:00:00+00:00", "published_display": "26 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Macnica, Inc. completed the acquisition of an 85.56% stake in GLOSEL Co., Ltd. from SAXA, Inc. and others for \u00a518.9 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwJBVV95cUxQOFJ4SXNsdFJub0hHQnVBNGNOWDAwVEppc0NPUElHME5Ic2J6dTR1VzlDdWJsOVdtcWdwdXo3TXYyOC1aNlM5ekJTUnlhS0NPNXlwa09CTzZoUnByRndFX1VhN2ZUMmJDYkNlRnVTcWpMQWJCTVkwaXNtXzRad094dWZrNG9QZG1ydVRGSmlJV2F3QnhoZm11a3FnSEM0aFhEWDVsU3YyVEFFZ2xjd183OVN1bGM5TEkzQXRnNUhIM2ZVYWxvY19KTzAzYUJIeUtvd29VVHQ0NGpQTXpGTzdzUEVab0JLR1JkUk5aVnZoaUdXazNmUXdKTHhWSXFFRmV0Xzgw?oc=5", "source_name": "marketscreener.com", "published_at": "2024-02-27T08:00:00+00:00", "published_display": "27 Feb 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REMEGEN CO., LTD. - H SHARES (9995) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQZEpmMGE3SFh3THpNS0p2ZGlUM0tQcjV5MTdwZW5Sc1VVMVEtVGFjbHROc0RTZmh6YWpFc2Q5VDVzWFJtZ2JSLTdYdzk5MFFOc0tKM2VlV25fR1lwaEhXNGhXb1RVTEJEdVFHWWNqNWgwS2hqR1BsVHJvTUxWVU5IclNsbGt6LTN6QWhQTEd0SQ?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-11-09T08:00:00+00:00", "published_display": "09 Nov 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 7, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 7, "score": 50, "total": 7, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 84.1, "latest_week": "2026-07-10", "one_week_move": -4.2, "four_week_move": 12.8, "twelve_week_move": -29.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.604609, "market_dynamics_buy_signal": false, "relative_strength": 2.113191, "fair_value_gap": 75.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 49.3191, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.2% over one week, +12.8% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "\u5bcc\u9014\u725b\u725b", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "thebambooworks.com", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "hkex.com.hk", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 7}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "7", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.2% over one week, +12.8% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Shareholder Meeting Live | RemeGen: Has Assembled a New Team to Expand Hospital Channels or May Seek Bundled BD Licensing Partnerships"}], "updated_at": "2026-07-18T05:30:57.563763+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}